| Grant number: | 15/12673-5 |
| Support Opportunities: | Scholarships in Brazil - Doctorate |
| Start date: | September 01, 2016 |
| End date: | February 29, 2020 |
| Field of knowledge: | Health Sciences - Physiotherapy and Occupational Therapy |
| Principal Investigator: | Carlos Amilcar Parada |
| Grantee: | Willians Fernando Vieira |
| Host Institution: | Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil |
| Associated scholarship(s): | 18/05108-8 - Direct influence of low-level laser irradiation on neurons: an electrophysiological study to helping comprise analgesic effects of infrared light in diabetic neuropathy, BE.EP.DR |
Abstract Diabetic neuropathy is manifested in about 60% of diabetic patients and is among the leading causes of amputation of peripheral members. Among the diagnosed cases of neuropathic pain, related to diabetic neuropathy is 30%. Although electrophysiological and morphological aspects of diabetic neuropathic pain are known, little is known about its development and progression, making difficult effective therapies. More recently, several studies have demonstrated a close correlation between the development of diabetic neuropathy and the increase of pro-inflammatory cytokines in the dorsal root ganglia (DRG), for example, the interleukin 1² (IL-1²) and tumor necrosis factor-alpha (TNF-±), which also act as signaling pathway activators of mitogen-activated protein kinases (MAPKs). Among other non-pharmacological therapies, low-level laser (light) therapy (LLLT) may be used as a treatment in cases of diabetic neuropathy. The results of clinical studies involving the effects of LLLT in the peripheral nervous system (PNS) are encouraging but inconclusive when it comes to pain of neuropathic origin in general. Little is known about the influence of LLLT activation and / or inhibition of signaling pathways related to diabetic neuropathy, such as the MAPK pathway (involving the p38 proteins, c-Jun N-terminal and ERK, and their phosphorylated forms). From this, the objective of this study will confirm the antihyperalgesic effect of LLLT in rats with diabetic neuropathy induced by systemic administration of streptozotocin. That said, we check whether the antihyperalgesic effect expected with this non-drug therapy is correlated with decreased levels of proinflammatory cytokines such as IL-1² and TNF-±, and expression of MAPK (p38, c- Jun N-terminal and ERK) in DRG. | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |